LiquidHub acquires Eveo to form new health offering

The agency founded by Olivier Zitoun in 1999 has been snapped up as part of LiquidHub's push to offer multi-disciplinary capabilities.

Five things for pharma marketers to know: Tuesday, June 27, 2017

Five things for pharma marketers to know: Tuesday, June 27, 2017

Merck announces positive trial results for CETP inhibitor; Purdue Pharma defends withholding of OxyContin marketing material; Roche's experimental haemophilia drug significantly cuts bleed rate

Pfizer celebrates the faces behind its vaccines with documentary

Pfizer celebrates the faces behind its vaccines with documentary

The video is part of Pfizer's ongoing corporate ad campaign Before it Became a Medicine.

Standing out in crowded cancer market

Standing out in crowded cancer market

Opdivo's marketing campaigns need to both market to and educate consumers about the new immunotherapy cancer treatment.



Lance Paull, executive creative director at Klick Health, discusses the creative element as part of developing strategies for clients, from the Cannes Lions Health International Festival of Creativity..


Five things for pharma marketers to know: Monday, June 26, 2017

Five things for pharma marketers to know: Monday, June 26, 2017

The performance of generic drugs is not always guaranteed; the FDA approves a new blood thinner; Gottlieb wants rejection letters public

PulseCX promotes David Zaritsky to CEO

PulseCX promotes David Zaritsky to CEO

Zaritsky succeeds Jay Bolling, who becomes executive chairman

Five things for pharma marketers to know: Friday, June 23, 2017

Five things for pharma marketers to know: Friday, June 23, 2017

Novartis drug prevents heart attacks and strokes, per trial; Senate lawmakers unveil healthcare bill; Pfizer receives CRL for Epogen biosimilar

Five things for pharma marketers to know: Thursday, June 22, 2017

Five things for pharma marketers to know: Thursday, June 22, 2017

The FDA plans public meeting to encourage generic competition; Mylan reportedly offered rebates to six Medicaid programs; Republicans to present draft bill for Obamacare replacement

The FDA attempts to understand how disclosures affect drug ads

The FDA attempts to understand how disclosures affect drug ads

The FDA recently proposed studies designed to determine how disclosures in drug ads affect how viewers frame information.

Five things for pharma marketers to know: Wednesday, June 21, 2017

Five things for pharma marketers to know: Wednesday, June 21, 2017

Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections

How Zicam made the most of TV's cold season

How Zicam made the most of TV's cold season

How Zicam proved that there is a better, more data-driven approach to buying and measuring TV advertising..

Allergan reaches the masses via unbranded Botox Facebook page

Allergan reaches the masses via unbranded Botox Facebook page

In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.

Area 23's Healthcare Agency of the Year win was four years in the making

Area 23's Healthcare Agency of the Year win was four years in the making

The FCB Health network won big this year with several campaigns, including work featuring a bra that detects breast cancer and an awareness campaign for human trafficking.

Five things for pharma marketers to know: Tuesday, June 20, 2017

Five things for pharma marketers to know: Tuesday, June 20, 2017

Novartis reports positive Phase-III results for Eylea competitor; AZ faces "critical transition point" in MYSTIC trial; physician shortage expected to rise

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers are increasingly facing blame from regulators, lawmakers, and the public as the list of lawsuits and investigations at the state and local levels grows.

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Under siege from intense competition and the rise of value-based contracts, diabetes drugmakers look to outcomes data to stand out.

Five things for pharma marketers to know: Monday, June 19, 2017

Five things for pharma marketers to know: Monday, June 19, 2017

Adamis receives FDA approval for EpiPen rival Symjepi; Clovis reports positive trial results for ovarian cancer drug Rubraca; hedge fund billionaire John Paulson joins Valeant board of directors

Day 2 at Lions Health: Watson's got its eye on you, Cannes

Day 2 at Lions Health: Watson's got its eye on you, Cannes

There's much for marketers to glean from stepping into different environments, working with new partners, and putting assets to work in new ways, said one speaker.

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

If there is one thing to take away from the opening day at the Cannes Lions International Festival of Creativity, it is this. Find the talks that inspire you, and then find the places with AC.